2019 Landry Fellowship RFA

CALL FOR APPLICATIONS

The 2019 Landry Cancer Research Fellowships

 

SUBMISSION DEADLINE: 5:00pm Friday, February 15, 2019

 

PURPOSE:

The Landry Cancer Research Fellowships are available to outstanding rising G3 students (current G2 students) working in all fields broadly relevant to basic or applied cancer research. Research projects relating to any aspect of cancer are eligible. Research projects relevant to Small Cell Lung Cancer are strongly encouraged. These fellowships will be held in the third and fourth year, and will provide 18 consecutive months of tuition and stipend support, discretionary funds to promote professional development and attendance of international/national conferences in cancer biology and related topics. Recipients may select either to begin funding in July 2019 or January 2020. Fellows and alumni of this program will serve as ambassadors and role models for the next generation of scientists through participation in Landry Cancer Biology Consortium training events.

 

 

ELIGIBILITY AND OTHER CRITERIA:

*   Applications are solicited from current HILS G2 students

*   Applicant's thesis project must be broadly relevant to basic or applied cancer research

 

QUALIFICATIONS

*   Quality and feasibility of the proposed research

*   Outstanding academic record

 

APPLICATION PACKAGE:

Submitted by applicant:

  • Curriculum Vitae
  • One page research statement, which can include a brief personal scientific background, goals of research, and at least one key finding. Your statement should describe your proposed area of thesis research and how it will contribute to one or more of the following areas:

1. a deeper fundamental understanding of biological, chemical, physical or design principles relevant to cancer in the broadest sense.

2. innovative interdisciplinary approaches and/or technologies that will facilitate transformative cancer research in the future.

3. novel therapeutic tools, applied science and/or strategies likely to push forward the frontier of cancer medicine.

Care should be taken to highlight current or potential collaborations contributing to the project that are likely to build lasting connections across department and school boundaries at Harvard University.

Submitted separately:

  • One letter of support from applicant's thesis adviser
  • One letter of support from a non-thesis adviser. This individual should be familiar with the applicant’s recent research potential.

(Two letters are expected in total)

Incomplete applications will not be accepted.

 

DEADLINE AND INSTRUCTIONS FOR EMAIL SUBMISSION

Submitted application materials and non-thesis adviser letter of support must be submitted via email by the deadline of 5:00pm EST on Friday, February 15th, 2019 to Ryan Lee (ryan_lee@hms.harvard.edu) with subject line "Landry Cancer Research Fellowship".

 

 

APPLICATION REVIEW

Following the application submission deadline, applications will be reviewed by experts within the Harvard community and ranked by members of the Landry Cancer Biology Consortium (LCBC) steering committee. Announcement of award receipt will occur on or by Friday, March 15th, 2019.

 

2019_lcbc_fellowship_rfa.docx19 KB